The global market for Non-Steroidal Anti-Inflammatory Drugs was estimated to be worth US$ 20600 million in 2023 and is forecast to a readjusted size of US$ 29690 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Non-Steroidal Anti-Inflammatory Drugs - Market

Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Steroidal Anti-Inflammatory Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Non-Steroidal Anti-Inflammatory Drugs by region & country, by Type, and by Application.

The Non-Steroidal Anti-Inflammatory Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Steroidal Anti-Inflammatory Drugs.

Market Segmentation

Scope of Non-Steroidal Anti-Inflammatory Drugs - Market Report

Report Metric	Details
Report Name	Non-Steroidal Anti-Inflammatory Drugs - Market
Forecasted market size in 2030	US$ 29690 million
CAGR	5.4%
Forecasted years	2024 - 2030
Segment by Type:	Non-Selective NSAIDs COX-2 Selective NSAIDs
Segment by Application	Dental Pain Muscle Aches Pain caused by Gout Bursitis Menstrual Cramps Fever Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc., Merck & Co., Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Non-Steroidal Anti-Inflammatory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Non-Steroidal Anti-Inflammatory Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Non-Steroidal Anti-Inflammatory Drugs - Market size in 2030?

Ans: The Non-Steroidal Anti-Inflammatory Drugs - Market size in 2030 will be US$ 29690 million.

Who are the main players in the Non-Steroidal Anti-Inflammatory Drugs - Market report?

Ans: The main players in the Non-Steroidal Anti-Inflammatory Drugs - Market are Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc., Merck & Co., Inc.

What are the Application segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs - Market report?

Ans: The Applications covered in the Non-Steroidal Anti-Inflammatory Drugs - Market report are Dental Pain, Muscle Aches, Pain caused by Gout, Bursitis, Menstrual Cramps, Fever, Others

What are the Type segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs - Market report?

Ans: The Types covered in the Non-Steroidal Anti-Inflammatory Drugs - Market report are Non-Selective NSAIDs, COX-2 Selective NSAIDs

1 Market Overview

1.1 Non-Steroidal Anti-Inflammatory Drugs Product Introduction

1.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast

1.3 Non-Steroidal Anti-Inflammatory Drugs Market Trends & Drivers

1.3.1 Non-Steroidal Anti-Inflammatory Drugs Industry Trends

1.3.2 Non-Steroidal Anti-Inflammatory Drugs Market Drivers & Opportunity

1.3.3 Non-Steroidal Anti-Inflammatory Drugs Market Challenges

1.3.4 Non-Steroidal Anti-Inflammatory Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Non-Steroidal Anti-Inflammatory Drugs Players Revenue Ranking (2023)

2.2 Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Company (2019-2024)

2.3 Key Companies Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base Distribution and Headquarters

2.4 Key Companies Non-Steroidal Anti-Inflammatory Drugs Product Offered

2.5 Key Companies Time to Begin Mass Production of Non-Steroidal Anti-Inflammatory Drugs

2.6 Non-Steroidal Anti-Inflammatory Drugs Market Competitive Analysis

2.6.1 Non-Steroidal Anti-Inflammatory Drugs Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Non-Selective NSAIDs

3.1.2 COX-2 Selective NSAIDs

3.2 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type

3.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Dental Pain

4.1.2 Muscle Aches

4.1.3 Pain caused by Gout

4.1.4 Bursitis

4.1.5 Menstrual Cramps

4.1.6 Fever

4.1.7 Others

4.2 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application

4.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region

5.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region (2019-2024)

5.1.3 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region (2025-2030)

5.1.4 Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

5.2.2 North America Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

5.3.2 Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

5.4.2 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

5.5.2 South America Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

5.6.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Non-Steroidal Anti-Inflammatory Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Non-Steroidal Anti-Inflammatory Drugs Sales Value

6.3 United States

6.3.1 United States Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

6.3.2 United States Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

6.4.2 Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

6.5.2 China Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

6.6.2 Japan Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

6.7.2 South Korea Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019-2030

6.9.2 India Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer Inc.

7.1.1 Pfizer Inc. Profile

7.1.2 Pfizer Inc. Main Business

7.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.1.4 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.1.5 Pfizer Inc. Recent Developments

7.2 Bayer AG

7.2.1 Bayer AG Profile

7.2.2 Bayer AG Main Business

7.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.2.4 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.2.5 Bayer AG Recent Developments

7.3 GSK plc

7.3.1 GSK plc Profile

7.3.2 GSK plc Main Business

7.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.3.4 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.3.5 Dr. Reddy’s Laboratories Ltd Recent Developments

7.4 Dr. Reddy’s Laboratories Ltd

7.4.1 Dr. Reddy’s Laboratories Ltd Profile

7.4.2 Dr. Reddy’s Laboratories Ltd Main Business

7.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.4.4 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.4.5 Dr. Reddy’s Laboratories Ltd Recent Developments

7.5 Viatris Inc

7.5.1 Viatris Inc Profile

7.5.2 Viatris Inc Main Business

7.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.5.4 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.5.5 Viatris Inc Recent Developments

7.6 Teva Pharmaceutical Industries Ltd.

7.6.1 Teva Pharmaceutical Industries Ltd. Profile

7.6.2 Teva Pharmaceutical Industries Ltd. Main Business

7.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.6.4 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments

7.7 Johnson And Johnson Services, Inc.

7.7.1 Johnson And Johnson Services, Inc. Profile

7.7.2 Johnson And Johnson Services, Inc. Main Business

7.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.7.4 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.7.5 Johnson And Johnson Services, Inc. Recent Developments

7.8 Merck & Co., Inc.

7.8.1 Merck & Co., Inc. Profile

7.8.2 Merck & Co., Inc. Main Business

7.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

7.8.4 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) & (2019-2024)

7.8.5 Merck & Co., Inc. Recent Developments

8 Industry Chain Analysis

8.1 Non-Steroidal Anti-Inflammatory Drugs Industrial Chain

8.2 Non-Steroidal Anti-Inflammatory Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Non-Steroidal Anti-Inflammatory Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Non-Steroidal Anti-Inflammatory Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Bayer

GSK

Dr. Reddy’s Laboratories Ltd.

Viatris

Teva Pharmaceutical Industries Ltd

Johnson and Johnson Services Inc.

Merck& Co. Inc

List of Tables

Table 1. Non-Steroidal Anti-Inflammatory Drugs Market Trends

Table 2. Non-Steroidal Anti-Inflammatory Drugs Market Drivers & Opportunity

Table 3. Non-Steroidal Anti-Inflammatory Drugs Market Challenges

Table 4. Non-Steroidal Anti-Inflammatory Drugs Market Restraints

Table 5. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Non-Steroidal Anti-Inflammatory Drugs Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Non-Steroidal Anti-Inflammatory Drugs Product Type

Table 9. Key Companies Time to Begin Mass Production of Non-Steroidal Anti-Inflammatory Drugs

Table 10. Global Non-Steroidal Anti-Inflammatory Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region (2019-2024) & (%)

Table 27. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Non-Steroidal Anti-Inflammatory Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2025-2030) & (US$ Million)

Table 31. Pfizer Inc. Basic Information List

Table 32. Pfizer Inc. Description and Business Overview

Table 33. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 34. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of Pfizer Inc. (2019-2024)

Table 35. Pfizer Inc. Recent Developments

Table 36. Bayer AG Basic Information List

Table 37. Bayer AG Description and Business Overview

Table 38. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 39. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of Bayer AG (2019-2024)

Table 40. Bayer AG Recent Developments

Table 41. GSK plc Basic Information List

Table 42. GSK plc Description and Business Overview

Table 43. GSK plc Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 44. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of GSK plc (2019-2024)

Table 45. GSK plc Recent Developments

Table 46. Dr. Reddy’s Laboratories Ltd Basic Information List

Table 47. Dr. Reddy’s Laboratories Ltd Description and Business Overview

Table 48. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 49. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of Dr. Reddy’s Laboratories Ltd (2019-2024)

Table 50. Dr. Reddy’s Laboratories Ltd Recent Developments

Table 51. Viatris Inc Basic Information List

Table 52. Viatris Inc Description and Business Overview

Table 53. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 54. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of Viatris Inc (2019-2024)

Table 55. Viatris Inc Recent Developments

Table 56. Teva Pharmaceutical Industries Ltd. Basic Information List

Table 57. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 58. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 59. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of Teva Pharmaceutical Industries Ltd. (2019-2024)

Table 60. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 61. Johnson And Johnson Services, Inc. Basic Information List

Table 62. Johnson And Johnson Services, Inc. Description and Business Overview

Table 63. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 64. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of Johnson And Johnson Services, Inc. (2019-2024)

Table 65. Johnson And Johnson Services, Inc. Recent Developments

Table 66. Merck & Co., Inc. Basic Information List

Table 67. Merck & Co., Inc. Description and Business Overview

Table 68. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Products, Services and Solutions

Table 69. Revenue (US$ Million) in Non-Steroidal Anti-Inflammatory Drugs Business of Merck & Co., Inc. (2019-2024)

Table 70. Merck & Co., Inc. Recent Developments

Table 71. Key Raw Materials Lists

Table 72. Raw Materials Key Suppliers Lists

Table 73. Non-Steroidal Anti-Inflammatory Drugs Downstream Customers

Table 74. Non-Steroidal Anti-Inflammatory Drugs Distributors List

Table 75. Research Programs/Design for This Report

Table 76. Key Data Information from Secondary Sources

Table 77. Key Data Information from Primary Sources

Table 78. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Non-Steroidal Anti-Inflammatory Drugs Product Picture

Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Non-Steroidal Anti-Inflammatory Drugs Report Years Considered

Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2023

Figure 7. Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Non-Selective NSAIDs Picture

Figure 9. COX-2 Selective NSAIDs Picture

Figure 10. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Dental Pain

Figure 13. Product Picture of Muscle Aches

Figure 14. Product Picture of Pain caused by Gout

Figure 15. Product Picture of Bursitis

Figure 16. Product Picture of Menstrual Cramps

Figure 17. Product Picture of Fever

Figure 18. Product Picture of Others

Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global Non-Steroidal Anti-Inflammatory Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 23. Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 24. Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 25. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 26. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 27. South America Non-Steroidal Anti-Inflammatory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 28. South America Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 29. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 30. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 31. Key Countries/Regions Non-Steroidal Anti-Inflammatory Drugs Sales Value (%), (2019-2030)

Figure 32. United States Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 33. United States Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 34. United States Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 35. Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 36. Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 37. Europe Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 38. China Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 39. China Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 40. China Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 41. Japan Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 42. Japan Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 43. Japan Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 44. South Korea Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 45. South Korea Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 46. South Korea Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 47. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 49. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 50. India Non-Steroidal Anti-Inflammatory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 51. India Non-Steroidal Anti-Inflammatory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 52. India Non-Steroidal Anti-Inflammatory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 53. Non-Steroidal Anti-Inflammatory Drugs Industrial Chain

Figure 54. Non-Steroidal Anti-Inflammatory Drugs Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions